AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IO Biotech, Inc. Director's Dealing 2025

Jun 6, 2025

34883_dirs_2025-06-06_a8a1cff4-6858-401e-86e5-4dfef1993d14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2025-06-05

Reporting Person: Glaub Kathleen Sereda (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-05	Stock Option (Right to Buy)	$1.5	A	35144	Acquired	2035-06-05	Common Stock (35144)	Direct

Footnotes

F1: These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.